Structured evidence table for L-Carnitine Fatigue Systematic Review, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| L-Carnitine Fatigue Systematic Review | Objectives Medical nutrition therapy significantly impacts cardiovascular risk and overall health, but effects on muscle diseases remain unclear. | 1 | Talreja T (2026) | Nutritional interventions and dietary supplements in muscle diseases: a systematic review. |
| L-Carnitine Fatigue Systematic Review | In inflammatory myopathies, creatine (loading dose 20 g/day, maintenance 3 g/day) combined with exercise improved high-intensity functional performance in PM and DM over 6 months. | 1 | Talreja T (2026) | Nutritional interventions and dietary supplements in muscle diseases: a systematic review. |
| L-Carnitine Fatigue Systematic Review | In Duchenne muscular dystrophy, creatine (2-10 g/day for 8-16 weeks) improved maximal voluntary contraction and fatigue resistance. | 1 | Talreja T (2026) | Nutritional interventions and dietary supplements in muscle diseases: a systematic review. |
| L-Carnitine Fatigue Systematic Review | This systematic review evaluates the safety and efficacy of dietary interventions and supplements on muscle disease outcomes. | 1 | Talreja T (2026) | Nutritional interventions and dietary supplements in muscle diseases: a systematic review. |
| L-Carnitine Fatigue Systematic Review | Fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are chronic multisystem disorders characterized by persistent fatigue, pain, cognitive dysfunction, sleep disturbances, and reduced quality of life. | 4 | Abanades S (2026) | Micronutrition as a Therapeutic Strategy for Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Narrative Review. |
| L-Carnitine Fatigue Systematic Review | Increasing evidence implicates mitochondrial dysfunction, oxidative and nitrosative stress, immune dysregulation, and altered redox and nicotinamide adenine dinucleotide (NAD + ) metabolism as interconnected mechanisms contributing to fatigue, although the strength of evidence varies across these pathways. | 4 | Abanades S (2026) | Micronutrition as a Therapeutic Strategy for Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Narrative Review. |
| L-Carnitine Fatigue Systematic Review | This narrative review critically examines the mechanistic and clinical evidence supporting mitochondrial-oriented micronutritional interventions in fibromyalgia and ME/CFS, including NAD + precursors, B-complex vitamins, magnesium, coenzyme Q10, alpha-lipoic acid, GlyNAC, L-carnitine, pyrroloquinoline quinone, taurine, and creatine. | 4 | Abanades S (2026) | Micronutrition as a Therapeutic Strategy for Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Narrative Review. |
Source documents